Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (72)
  • 2024 (93)
  • 2023 (135)
  • 2022 (150)
  • 2021 (86)
  • 2020 (8)
  • 2019 (3)
  • 2018 (2)
  • 2017 (2)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Major Law Enforcement Operation (267)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Overdose (321)
  • Diversion Division (242)

Drug Name

  • Fentanyl (243)
  • Heroin (49)
  • Opioids (49)
  • Oxycodone (46)
  • Cocaine (40)
  • Synthetic Opioids (33)
  • Methamphetamine (28)
  • Hydromorphone (14)
  • Benzodiazepines (8)
  • Marijuana (Cannabis) (7)
  • Morphine (7)
  • Ketamine (4)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • Ecstasy/MDMA (2)
  • K2/Spice (2)
  • Marijuana Concentrates (2)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • Washington, DC (93)
  • New York (73)
  • San Diego (36)
  • New England (35)
  • Seattle (35)
  • St. Louis (35)
  • Atlanta (33)
  • Chicago (23)
  • Houston (21)
  • Los Angeles (21)
  • Miami (21)
  • El Paso (19)
  • Omaha (17)
  • San Francisco (17)
  • New Jersey (16)
  • Dallas (14)
  • Sede (11)
  • New Orleans (10)
  • Louisville (6)
  • Phoenix (5)
  • Rocky Mountain (5)
  • Detroit (3)
  • Philadelphia (2)
Clear All Results
PRESS RELEASE

Santa Clarita Man Charged with Distributing Opioid More Powerful than Fentanyl and Causing Victim’s Overdose Death

Noviembre 22, 2024
LOS ANGELES – A Santa Clarita man has been arraigned on an indictment alleging he distributed protonitazene – a novel synthetic opioid that is up to three times more powerful than fentanyl – which resulted in a victim’s fatal overdose this spring, the Justice Department announced today. Benjamin Anthony Collins...
Noviembre 22, 2024
PRESS RELEASE

Hospital in Washington Agrees to Pay $15,000 Penalty and Implement Corrective Actions to Address Theft of Controlled Substances

Noviembre 18, 2024
Spokane, Wash. - Mid-Valley Hospital and Clinic in Omak, Washington, agreed to pay a $15,000 Controlled Substances Act penalty and to institute corrective actions in regard to its pharmacy and controlled substances policy and procedures. To protect the public, the Controlled Substances Act and its implementing regulations place legal responsibilities...
Noviembre 18, 2024
PRESS RELEASE

Nearly 630,000 Pounds of Unneeded Medications Collected on DEA’s National Prescription Drug Take Back Day

Noviembre 15, 2024
MIAMI — Drug Enforcement Administration (DEA) and more than 4,400 law enforcement partners recently collected nearly 630,000 pounds of unused medications at 4,600 locations nationwide. This effort to empty medicine cabinets helps prevent drug misuse before it starts. Since its inception, DEA’s National Prescription Drug Take Back Day has removed...
Noviembre 15, 2024
PRESS RELEASE

Covetrus Agrees To Pay $1,125,000 for Failing to Adequately Address Suspicious Opioid Orders and for Inadequate Recordkeeping Practices

Octubre 30, 2024
BOSTON – The U.S. Attorney’s Office has reached a $1,125,000 settlement with Covetrus North America, LLC (Covetrus NA) to resolve allegations that it violated the Controlled Substances Act and related regulations. Covetrus NA, headquartered in Portland, Maine, is a company that distributes veterinary medicine to customers worldwide. Under the settlement...
Octubre 30, 2024
PRESS RELEASE

U.S. Attorney’s Office and DEA Announce Fatal Fentanyl Overdose Task Force

Octubre 28, 2024
Baltimore, Maryland – Erek L. Barron, U.S. Attorney for the District of Maryland and Jarod Forget, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) Washington Division, announced that their agencies have formed the Maryland Fatal Fentanyl Overdose Task Force (“MFFOTF”). The alarming rate of overdoses in Maryland has...
Octubre 28, 2024
PRESS RELEASE

Physician, Physician Assistant, and Practice Pay $300K to Resolve Controlled Substances Act Allegations

Octubre 23, 2024
BERLIN, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, and Stephen P. Belleau, Acting Special Agent in Charge of the Drug Enforcement Administration for New England, today announced that Dr. STEVEN SHIFREEN, Physician Assistant CHRISTOPHER NORVAL, and MULTICARE MUSCULOSKETETAL MEDICINE AND PAIN MANAGEMENT ASSOCIATES, P.C...
Octubre 23, 2024
PRESS RELEASE

Former Nurse Pleads Guilty in Connection with Diverting Fentanyl from ICU Patient

Octubre 08, 2024
CONCORD, N.H. – A Northfield woman has pleaded guilty in federal court for diverting fentanyl from an ICU patient at Concord Hospital, U.S. Attorney Jane E. Young announces. Lisa Richardson, 48, pleaded guilty to one count of Tampering with Consumer Products. U.S. District Court Judge Landya McCafferty scheduled sentencing for...
Octubre 08, 2024
PRESS RELEASE

Multiple Pharmaceutical Distributor Executives, Sales Representatives and Brokers Charged in Connection with Unlawful Sales of over 70M Opioid Pills

Octubre 03, 2024
HOUSTON - Charges have been unsealed as part of a larger enforcement action related to the unlawful distribution of nearly 70 million opioid pills and over 30 million doses of other commonly abused prescription drugs to alleged Houston-area pill-mill pharmacies. Three Houston-area pharmacy operators were also charged for their role...
Octubre 03, 2024
PRESS RELEASE

El Paso Man Sentenced to 15 Years in Federal Prison for Dealing Fentanyl, Causing Death

Octubre 01, 2024
EL PASO, Texas – An El Paso man was sentenced in federal court to 180 months in prison for distribution of fentanyl, causing death or serious bodily injury. According to court documents, Adrian David Perez Jr., 21, sold counterfeit M-30 pills laced with fentanyl to an individual on Oct. 13...
Octubre 01, 2024
PRESS RELEASE

12 Kansas City-Area Men Indicted for Fentanyl Trafficking, Illegal Firearms

Septiembre 13, 2024
KANSAS CITY, Mo. – A dozen Kansas City metropolitan area men have been indicted by a federal grand jury for their roles in a conspiracy to distribute fentanyl, which resulted in at least one death, and to illegally possessing firearms. Justin D. Rivera, also known as “JD,” 20, Yael Figueroa...
Septiembre 13, 2024
Showing 81 - 90 of 551 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Current page 9
  • Página 10
  • Página 11
  • Página 12
  • Página 13
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster